Mainolfi Nello bought KYMR
July 1, 2026 · Form 4 insider transaction
Mainolfi Nello bought 80,000 shares of Kymera Therapeutics, Inc. at $2.08 per share, a transaction worth $166.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
80,000
Price
$2.08
Total value
$166.4K
InsiderMainolfi Nello
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 1, 2026
Filing dateJuly 2, 2026
Shares owned after746,568
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.; This number includes 373 shares acquired under the Registrant's employee stock purchase plan.